Clear Improvement in Real-World Chronic Myeloid Leukemia Survival: A Comparison With Randomized Controlled Trials

Autor: Claudia Vener, Silvia Rossi, Pamela Minicozzi, Rafael Marcos-Gragera, Hélène A. Poirel, Marc Maynadié, Xavier Troussard, Gabriella Pravettoni, Roberta De Angelis, Milena Sant, the EUROCARE-6 Working Group, M. Hackl, E. Van Eycken, Z. Valerianova, M. Sekerija, P. Pavlou, L. Dušek, H. Storm, M. Mägi, K. Innos, N. Malila, J. Pitkäniemi, M. Velten, X. Troussard, A.M. Bouvier, V. Jooste, A.V. Guizard, G. Launoy, S. Dabakuyo Yonli, M. Maynadié, A.S. Woronoff, J.B. Nousbaum, G. Coureau, A. Monnereau, I. Baldi, K. Hammas, B. Tretarre, M. Colonna, S. Plouvier, T. D’Almeida, F. Molinié, A. Cowppli-Bony, S. Bara, C. Schvartz, G. Defossez, B. Lapôtre-Ledoux, P. Grosclaude, S. Luttmann, R. Stabenow, A. Nennecke, J. Kieschke, S. Zeissig, B. Holleczek, A. Katalinic, H. Birgisson, D. Murray, P.M. Walsh, G. Mazzoleni, F. Vittadello, F. Cuccaro, R. Galasso, G. Sampietro, S. Rosso, M. Magoni, M. Ferrante, A. Sutera Sardo, M.L. Gambino, P. Ballotari, E. Giacomazzi, S. Ferretti, A. Caldarella, G. Manneschi, G. Gatta, M. Sant, P. Baili, F. Berrino, L. Botta, A. Trama, R. Lillini, A. Bernasconi, S. Bonfarnuzzo, C. Vener, F. Didonè, P. Lasalvia, G. Del Monego, M.C. Magri, L. Buratti, D. Serraino, L. Dal Maso, R. Capocaccia, R. De Angelis, E. Demuru, C. Di Benedetto, S. Rossi, M. Santaquilani, S. Venanzi, R.A. Filiberti, S. Iacovacci, V. Gennaro, A.G. Russo, G. Spagnoli, L. Cavalieri d’Oro, M. Fusco, M.F. Vitale, M. Usala, F. Vitale, M. Michiara, G. Chiranda, G. Cascone, E. Spata, L. Mangone, F. Falcini, R. Cavallo, D. Piras, A. Madeddu, F. Bella, A.C. Fanetti, S. Minerba, G. Candela, T. Scuderi, R.V. Rizzello, F. Stracci, G. Tagliabue, M. Rugge, A. Brustolin, S. Pildava, G. Smailyte, M. Azzopardi, T.B. Johannesen, J. Didkowska, U. Wojciechowska, M. Bielska-Lasota, A. Pais, J.L. Pontes, A. Miranda, C. Safaei Diba, V. Zadnik, T. Zagar, C. Sánchez-Contador Escudero, P. Franch Sureda, A. Lopez de Munain, M. De-La-Cruz, M.D. Rojas, A. Aleman, A. Vizcaino, R. Marcos-Gragera, M.J. Sanchez, M.D. Chirlaque, M. Guevara Eslava, E. Ardanaz, J. Galceran, M. Carulla, Y. Bergeron, C. Bouchardy, S. Mohsen Mousavi, A. Bordoni, O. Visser, J. Rashbass, A. Gavin, D. Morrison, D. W. Huws

Publikováno v: Frontiers in Oncology, Vol 12 (2022)

Tyrosine kinase inhibitors (TKIs) have been improving the prognosis of patients with chronic myeloid leukemia (CML), but there are still large differences in survival among European countries. This raises questions on the added value of results from

Externí odkaz: https://doaj.org/article/649f525cc7c94af9aad47bb9b9bdb1f4

Concordance Between Biopsy and Radical Prostatectomy Gleason Scores: Evaluation of Determinants in a Large-Scale Study of Patients Undergoing RARP in Belgium

Autor: G. De Coster, N. Van Damme, E. Van Eycken, C. Soenens, B. Van Cleynenbreugel, Be-RALP registry, Peter Dekuyper, T Roumeguère, T Quackels, Steven Joniau, Filip Ameye

Publikováno v: Pathology & Oncology Research. 26:2605-2612

To determine whether Gleason scores were concordant between prostate biopsies (bGS) and the definitive resection specimen (pGS) excised with robot-assisted radical prostatectomy (RARP); to identify clinical and pathological factors that might predict

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1558fc1fbab5f20f3c86120c386f98a3
https://doi.org/10.1007/s12253-020-00860-w

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

North European comparison of treatment strategy and survival in older patients with resectable gastric cancer: A EURECCA upper gastrointestinal group analysis

Autor: Johan L. Dikken, Geir Olav Hjortland, E. Van Eycken, Henk H. Hartgrink, H. De Schutter, Johanneke E.A. Portielje, Ioannis Rouvelas, C.J.H. van de Velde, H. J. Larsson, W.O. de Steur, Lone Susanne Jensen, Rob H.A. Verhoeven, Egil Johnson, Marije Slingerland, Esther Bastiaannet, Y.H.M. Claassen, Jan Johansson, William H. Allum

Publikováno v: EJSO-European Journal of Surgical Oncology, 44(12), 1982-1989
European journal of surgical oncology, 44(12), 1982-1989. W.B. Saunders Ltd
Claassen, Y H M, Dikken, J L, Hartgrink, H H, de Steur, W O, Slingerland, M, Verhoeven, R H A, van Eycken, E, de Schutter, H, Johansson, J, Rouvelas, I, Johnson, E, Hjortland, G O, Jensen, L S, Larsson, H J, Allum, W H, Portielje, J E A, Bastiaannet, E & van de Velde, C J H 2018, ' North European comparison of treatment strategy and survival in older patients with resectable gastric cancer : A EURECCA upper gastrointestinal group analysis ', European Journal of Surgical Oncology, vol. 44, no. 12, pp. 1982-1989 . https://doi.org/10.1016/j.ejso.2018.09.014

Background: As older gastric cancer patients are often excluded from randomized clinical trials, the most appropriate treatment strategy for these patients remains unclear. The current study aimed to gain more insight in treatment strategies and rela

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d40eddeabaed42285fb7636ffd284302
https://doi.org/10.1016/j.ejso.2018.09.014

International comparison of treatment strategy and survival in metastatic gastric cancer

Autor: Lone Susanne Jensen, Jakob Hedberg, Marije Slingerland, Rob H.A. Verhoeven, Egil Johnson, Geir Olav Hjortland, Esther Bastiaannet, T. Koessler, J. L. Dikken, E. Van Eycken, William H. Allum, Mats Lindblad, C.J.H. van de Velde, Mickael Chevallay, H. J. Larsson, W.O. de Steur, Henk H. Hartgrink, H. De Schutter, Yvette Claassen

Publikováno v: BJS Open. 3:56-61

Background In the randomized Asian REGATTA trial, no survival benefit was shown for additional gastrectomy over chemotherapy alone in patients with advanced gastric cancer with a single incurable factor, thereby discouraging surgery for these patient

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a482e2924782b4c45256f5d95fb92b93
https://doi.org/10.1002/bjs5.103